Flamel Technologies Update
CEDEX, France, Nov. 26, 2008-Flamel Technologies has posted an updated presentation on its website. The new presentation accounts for the initiation of an additional feasibility study to evaluate Medusa in conjunction with therapeutic vaccines. The work is being conducted with a top-twenty pharmaceutical company with which the company is already engaged on two other projects. The presentation may be accessed at www.flamel.com.
Charles Marlio, Director of Strategic Planning and Investor Relations
FRANCE: (011) 33-4-72-78-34-34
US: (1) (202) 862-8400
Posted: November 2008